Intensity Modulated Radiation Therapy (IMRT) for Breast Cancer

Slides:



Advertisements
Similar presentations
Breast Cancer Patient Issues in Family Practice: An Interactive Session.
Advertisements

History of the randomized evidence on early breast cancer overall survival: Radiation vs no radiation after mastectomy L. Vakaet 2006.
10th Annual Lung Cancer Conference Radiation Oncology
NCI Workshop Advanced Technologies for Breast Cancer.
San Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapy Kathleen C. Horst, M.D. Assistant Professor Department of Radiation Oncology Stanford.
Standard Treatment Not Depicted: Variation in Intensity Variation in shape.
IMRT For Breast Cancer: To do or not to do?
Understanding Radiation Therapy Tamara A. LaCouture, M.D. Chief & Chair Department of Radiation Oncology Cooper University Hospital Assistant Professor.
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
Hot topics in breast radiotherapy Mark Beresford.
Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
Radiotherapy for Kidney cancer
Management of DCIS Fei-Fei Liu Radiation Oncologist/Senior Scientist.
Postmastectomy Radiation therapy (PMRT): Who needs it in 2008? Carol Marquez, M.D. Associate Professor, Department of Radiation Medicine Oregon Health.
Conformal Therapy for Lung Cancer B. Schicker, F.J. Schwab*, U. Götz Institute of Radiotherapy and Radiation Oncology St. Vincenz-Krankenhaus Limburg *Clinic.
Ductal Carcinoma In Situ (DCIS)
Radiotherapy to the female pelvis
Breast Cancer: The Profile Ma. Belen E. Tamayo,M.D. Medical Oncologist Makati Medical Center The Medical City.
Ischemic Heart Disease Following Left Breast Irradiation with Active Breathing Control (ABC): 10 year Outcomes and Risk Modeling Abstract 1027 Presenter:
Clinico-Dosimetric Correlation for Acute and Chronic Gastrointestinal Toxicity in Patients of Locally Advanced Carcinoma Cervix Treated With Conventional.
Radiation Breast Oncology Highlights of SABC 2006 Alison Bevan, MD PhD UCSF Radiation Oncology January, 2007.
Post-mastectomy radiotherapy Sabine Balmer Majno Radiation Oncology Geneva University Hospital SRO Tutorial 20/09/2006.
BREAST MRI IN RADIATION THERAPY PLANNING MARSHA HALEY, M.D. ASSISTANT PROFESSOR UNIVERSITY OF PITTSBURGH CANCER INSTITUTE PITTSBURGH, PENNSYLVANIA, USA.
Evidence Based For invasive breast cancer BCT is Tumor excision, axillary node dissection, whole breast radiation Modified mastectomy is total mastectomy.
These slides were released by the speaker for internal use by Novartis
Targeted Intraoperative Radiotherapy versus Whole Breast Radiotherapy for Breast Cancer (TARGIT-A Trial): An International, Prospective, Randomised, Non-Inferiority.
Clinical decisions in the optimization process I. Emphasis on tumor control issues Avi Eisbruch University of Michigan.
1789 patients, 1982 – 1989, premenopausal, node + or Tumor > 5cm, M0 Total mastectomy, level I + II (partly) + CMF +/- 50Gy/25fx (electrons + photons)
Radical Mastectomy is no longer the standard Improved adjuvant and neoadjuvant therapy Chemotherapy Endocrine therapy Radiation treatment Reconstruction.
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl,
Adjuvant chemotherapy – When should surgeons recommend? Joint Hospital Surgical Grand Round Dr Lorraine Chow Ruttonjee Hospital.
Cancer.orgPredict Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung.
Hormone treatment combined with radiotherapy
Approaching early stage disease
 Gy  Decreased fibrosis  Enhanced local control  Deep seeded tumors isch&source=hp&biw=1366&bih=624&q=radia.
Combined Modality Treatment of Locally Advanced Prostate Cancer: Radiation Therapy (RT) with Concurrent Androgen Deprivation Therapy (ADT) Howard Sandler.
Basis and Outcome of Axillary Dissection for Node Negative Axilla Gurpreet Singh Dept. Of Surgery P.G.I.M.E.R. These Power Point presentations are free.
Breast Cancer Surgery: Can I still keep my breast? By Dr. Khudair Al-Rawaq.
Inferring the Effects of Cancer Treatment: Divergent Results from the Early Breast Cancer Trialists’ Collaborative Group Meta-analyses of Randomized Trials.
Refining Radiotherapy for Early Breast Cancer: The Challenges. David Dodwell Radiotherapy in Practice Sheffield Hallam University October 2010.
This house believes that routine 3D planning and treatment of breasts should be mandatory Proposing the Motion.
'This house believes that routine 3D planning and treatment of breast cancer should be mandatory' Dr Heidi Probst Sheffield Hallam University.
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.
PHASE II TRIAL OF HYPOFRACTIONATED BREAST IRRADIATION WITH VMAT-SIB TECHNIQUE: TOXICITY AND EARLY CLINICAL ASSESSMENT IN 270 PATIENTS F. De Rose¹, F. Alongi¹,
MA.17R: Reduced Risk of Recurrence With Extending Adjuvant Letrozole Beyond 5 Yrs in Postmenopausal Women With Early-Stage Breast Cancer CCO Independent.
방사선종양학과 - 혈액종양내과 Joint Conference 경희의료원 방사선종양학과 R4 공 문 규.
Emily Tanzler, MD Waseet Vance, MD
Radiation therapy for Early Stage Prostate Cancer
Treatment options for HPV+ disease
RCR breast radiotherapy consensus guidelines
Baseline Respiratory Parameters Documented
Surgical Management of the Breast in Breast Cancer
Figure 2 Underreporting by physicians of specific treatment-associated symptoms by physicians in the TORCH trial Figure 2 | Underreporting by physicians.
Radiotherapy for Metastatic Spinal Cord Compression
Intellectual property of the EBCTCG trialists.
Personalisiertes Vorgehen im Bereich des Lymphabflusses
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.
Figure 3 Clinical trial design in charged-particle therapy (CPT)
BAT for HFrEF Trial design: Patients with chronic systolic HF were randomized in a 1:1 fashion to either baroreceptor activation therapy (BAT) or control.
Chapter 17 Intensity-Modulated Radiation Therapy
AMACING Trial design: Patients with chronic kidney disease undergoing intravascular iodinated contrast administration were randomized to prophylactic hydration.
Figure 2 Variations between planned and delivered doses of radiation
Continuing Adjuvant Tamoxifen to 10 Years
Technical Advances of Radiation Therapy for Thymic Malignancies
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient.
高雄榮民總醫院耳鼻喉頭頸部 林陞樵 林曜祥 康柏皇 張庭碩
Proton Therapy for Thymic Malignancies: Multi-institutional Patterns-of-Care and Early Clinical Outcomes from the Proton Collaborative Group Registry &
Presentation transcript:

Intensity Modulated Radiation Therapy (IMRT) for Breast Cancer Vincent Remouchamps Service de Radiothérapie Clinique et Maternité Ste Elisabeth Namur www.cmsenamur.be Belgian Breast Meeting 2008 October 3-4, Brussels

Intensity Modulated Radiation Therapy(IMRT) for Breast Cancer Clinical problem: skin toxicity Technical solutions: IMRT and 3D optimization Clinical outcome from 2 Randomized Trials Ontario (Donovan et al. Radioth. Oncol. 2007 Mar;82(3):254-64) Royal Marsden (Pignol et al. JCO 2008; 26(13):2085-92) Combination with breath hold (for heart protection) Combination with complex radiation fields (nodal) Conclusions

Sagital isodoses view Kestin et al, IJROBP 2000 Standard Wedges Desquamation, Oedema Acute Skin Side Effects 115% 110% 105% 100% 95% 90% Hot spots

3D Optimisation

Sagital isodoses view Standard Filters Optimized 3D / IMRT 115% 110% 105% 100% 95% 90%

Electronic compensators Breast IMRT Follow the shape of the breast

Donovan et al Radiother. Oncol Donovan et al Radiother. Oncol. 2007 Mar;82(3):254-64 240 patients, randomized

Donovan et al: Any palpable induration:

Pignol et al, J Clin Oncol Pignol et al, J Clin Oncol. 2008 May 1;26(13):2085-92 358 patients, Randomized

Radiotherapy after breast-conserving surgery, generally with axillary clearance (BCSRT) in all women (7311 women, 17% with node +disease) META-ANALYSE: EBCTCG Lancet 2005; 366: 2087-2106

Effect of radiotherapy on non-breast cancer mortality (29 623 women) Why non-breast cancer surmortality? Main reasons: Heart toxicity and lung cancer Cohort studies: Mostly left-sided radiation META-ANALYSE: EBCTCG Lancet 2005; 366: 2087-2106

To Protect the Heart: Heart Deep Inspiration Breath Hold Free Breathing

Nodal extension Anatomy of the lymphatic routes of the breast. In: Del Regato JA, Spjut HJ: Ackerman and del Regato’s Cancer: Diagnosis, Treatment, and Prognosis, ed. 6 St. Louis, CV Mosby, 1985

Conclusions: Breast « IMRT » improve the radiation dose homogeneity is feasable reduces acute and chronic toxicities (level 1) can be combined with advanced techniques breath hold for heart protection perfect junctioning